Search research articles
Contact Us
Filters
Showing results (61-70 of 260) with videos related to
Page
of 26
Sort By:
Journal of Affective Disorders
|
January 1, 2003
Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania
Robert W Baker, Denái R Milton, Virginia L Stauffer, et al.
Harvard Review of Psychiatry
|
April 27, 2010
Bipolar depression: overview and commentary
Ross J Baldessarini, Eduard Vieta, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry
|
November 13, 2009
Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis
Franco Benazzi, Michael Berk, Mark A Frye, et al.
International Journal of Bipolar Disorders
|
October 28, 2024
Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal trial
Karimah S Bell Lynum, Christine F Castro, Zhen Zhang, et al.
Journal of Affective Disorders
|
March 28, 2006
Clinical relevance of depressive symptom improvement in bipolar I depressed patients
Doug Williamson, Eileen Brown, Roy H Perlis, et al.
Journal of Affective Disorders
|
December 8, 2021
Chronbiologically-based sub-groups in bipolar I disorder: A latent profile analysis
Robert Gonzalez, Alok Dwivedi, Jamie Zeitzer, et al.
The Primary Care Companion for CNS Disorders
|
June 8, 2017
Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States
Mauricio Tohen, Daisy Ng-Mak, Krithika Rajagopalan, et al.
The Journal of Clinical Psychiatry
|
February 5, 2009
Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study
Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al.
International Clinical Psychopharmacology
|
July 15, 2025
Long-term safety and tolerability of lumateperone 42 mg in patients with bipolar disorder: results from a 6-month open-label extension study
Mauricio Tohen, Suresh Durgam, Susan G Kozauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 15, 2023
Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data
Konstantinos N Fountoulakis, Magdalini Ioannou, Mauricio Tohen, et al.
Page
of 26
Search research articles
Search
Showing results (61-70 of 260) with videos related to
Sort By:
Page
of 26
Journal of Affective Disorders
|
January 1, 2003
Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania
Robert W Baker, Denái R Milton, Virginia L Stauffer, et al.
Harvard Review of Psychiatry
|
April 27, 2010
Bipolar depression: overview and commentary
Ross J Baldessarini, Eduard Vieta, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry
|
November 13, 2009
Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis
Franco Benazzi, Michael Berk, Mark A Frye, et al.
International Journal of Bipolar Disorders
|
October 28, 2024
Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal trial
Karimah S Bell Lynum, Christine F Castro, Zhen Zhang, et al.
Journal of Affective Disorders
|
March 28, 2006
Clinical relevance of depressive symptom improvement in bipolar I depressed patients
Doug Williamson, Eileen Brown, Roy H Perlis, et al.
Journal of Affective Disorders
|
December 8, 2021
Chronbiologically-based sub-groups in bipolar I disorder: A latent profile analysis
Robert Gonzalez, Alok Dwivedi, Jamie Zeitzer, et al.
The Primary Care Companion for CNS Disorders
|
June 8, 2017
Patient Characteristics Associated With Use of Lurasidone Versus Other Atypical Antipsychotics in Patients With Bipolar Disorder: Analysis From a Claims Database in the United States
Mauricio Tohen, Daisy Ng-Mak, Krithika Rajagopalan, et al.
The Journal of Clinical Psychiatry
|
February 5, 2009
Tardive dyskinesia and the 3-year course of schizophrenia: results from a large, prospective, naturalistic study
Haya Ascher-Svanum, Baojin Zhu, Douglas Faries, et al.
International Clinical Psychopharmacology
|
July 15, 2025
Long-term safety and tolerability of lumateperone 42 mg in patients with bipolar disorder: results from a 6-month open-label extension study
Mauricio Tohen, Suresh Durgam, Susan G Kozauer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 15, 2023
Antidepressant efficacy of cariprazine in bipolar disorder and the role of its pharmacodynamic properties: A hypothesis based on data
Konstantinos N Fountoulakis, Magdalini Ioannou, Mauricio Tohen, et al.
Page
of 26